Medtronic
- Market cap
- 109.38B
- P/E (TTM)i
- 21.06
- P/Bi
- 2.18
- EPSi
- 3.73
- Div yieldi
- 3.33%
- 52W posi
- 44%
Anonymous reader poll. Unscientific, not investment advice.
Medtronic last traded at 85.51, down 1.81% on the session. Its market capitalisation is about 109.38B, the #176 most valuable US-listed company we track. Valuation-wise, the P/E sits at 21.67, 20% below the five-year average of 26.99. The stock also carries a trailing dividend yield of 3.33%. The 20 analysts covering the stock are, on balance, at Buy, targeting an average of 103.41 (+21%). Against a 52-week band of 72.06-102.92, the shares are currently 44% of the way up.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 2 weeks.
- Recent price momentum is -4.4% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 977 U.S. stocks StockVane covers.
Valuation B
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 21.7x | Better than 43% |
| Forward P/E | 19.4x | Better than 44% |
| Price / Sales | 3.2x | Better than 47% |
| P/E vs own 5-yr range | 10th pctl | Better than 87% |
Growth B-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 5.2% | Better than 45% |
| Net income CAGR (3Y) | 8.5% | Better than 56% |
| Free cash flow CAGR (3Y) | 5.8% | Better than 43% |
Profitability B
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 65.0% | Better than 79% |
| Operating margin | 18.8% | Better than 61% |
| Net margin | 13.2% | Better than 58% |
| Return on equity | 9.8% | Better than 37% |
| Return on invested capital | 7.0% | Better than 40% |
Momentum B-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 4.9% | Better than 66% |
| 6-month return | 2.7% | Better than 44% |
| 12-month return (ex latest month) | -2.0% | Better than 29% |
| Distance below 52-week high | 14.5% | Better than 62% |
Financial Health B-
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 2.1x | Better than 70% |
| Debt to assets | 56.5% | Better than 22% |
| Interest coverage | 9.6x | Better than 63% |
| Free cash flow / net income | 113.0% | Better than 51% |
Analyst View C
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 60.0% | Better than 34% |
| Upside to average target | 17.6% | Better than 34% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 87.09
- Open
- 87.40
- Day range
- 85.43 - 88.19
- Avg price
- 86.21
- Volume
- 55.89M
- Turnover
- 4.82B
- Turnover ratei
- 4.38%
- Volume ratioi
- 1.49
- Amplitudei
- 3.18%
- 52-week rangei
- 72.06 - 102.92
Valuation
- P/Ei
- 22.92
- P/E (TTM)i
- 21.06
- P/Bi
- 2.18
- EPSi
- 3.73
- Book value / shi
- 39.27
- Net profit
- 4.77B
- Net assets
- 50.23B
Share structure
- Market cap
- 109.38B
- Float capi
- 109.17B
- Shares out
- 1.28B
- Float sharesi
- 1.28B
Dividend & listing
- Div yield (TTM)i
- 3.33%
- Dividend (TTM)
- 2.85
- Listing date
- 1970-01-01
16.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-401.87M net over the window
Short interest
- Shares short
- 17.23M
- % of floati
- 1.35%
- Days to coveri
- 1.97
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Medtronic (MDT)?
Medtronic last traded at 85.51. The quote on this page refreshes every few seconds while US markets are open.
What is Medtronic's market cap?
About 109.38B.
What is the P/E ratio of Medtronic?
The trailing twelve-month P/E is 21.06, below its own 5-year average of 26.99 — toward the bottom of its historical range (4.87% percentile). See the Valuation tab for the full history.
Does Medtronic pay a dividend?
Yes. The trailing dividend yield is 3.33%. The 2025 payout was up 1.4% from 2024. See the Dividends tab for the full payment history.
Is Medtronic a buy according to analysts?
The consensus of 20 analysts is a Buy rating, with an average 12-month price target of 103.41, which implies 20.9% upside from the current price. This is not investment advice.
What is Medtronic's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Medtronic a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-08 07:29:28 · For reference only, not investment advice and not tailored to your situation.